Sumitomo Chemical Limited
SOMMY | OTC
$15.34
-$0.17 (-1.10%)
Oct 28, 2025, 1:54 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 | FY 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.61T | 2.45T | 2.9T | 2.77T | 2.29T | 2.23T |
Cost of Revenue | 1.88T | 1.95T | 2.07T | 1.52T | 1.52T | 1.52T |
Gross Profit | 725.48B | 499.7B | 820.93B | 873.86B | 771.2B | 706.76B |
Operating Income | 193.03B | -488.83B | -57.34B | 183B | 139.93B | 137.52B |
Interest Income | 17.65B | 73B | 70.84B | 59.19B | 19.87B | 13.18B |
Pretax Income | 58.09B | -462.79B | 231M | 251.14B | 137.8B | 130.48B |
Net Income | 38.59B | -311.84B | 6.99B | 162.13B | 46.04B | 30.93B |
Selling & General & Admin | 601.07B | 887.12B | 629.72B | 466.66B | 422.51B | 575.14B |
Research & Development | n/a | n/a | 195.6B | 171.92B | 178.65B | n/a |
Other Expenses | -68.63B | 101.4B | 52.94B | -16.96B | 32.92B | -5.9B |
Operating Expenses | 532.44B | 988.52B | 878.26B | 621.62B | 634.08B | 569.24B |
Interest Expense | 152.59B | 46.96B | 39.62B | 23.06B | 19.18B | 20.22B |
Selling & Marketing Expenses | n/a | n/a | 150.03B | 119.14B | 100.85B | n/a |
Cost & Expenses | 2.41T | 2.94T | 2.95T | 2.58T | 2.15T | 2.09T |
Income Tax Expense | 15.41B | 2.66B | 47.1B | 64.7B | 69.73B | 76.08B |
Shares Outstanding (Basic) | 327.32M | 327.07M | 327M | 327M | 327M | 327M |
Shares Outstanding (Diluted) | 327.3M | 327.07M | 327.06M | 327M | 327M | 327M |
EPS (Basic) | 117.95 | -953.45 | 21.35 | 495.80 | 140.80 | 94.55 |
EPS (Diluted) | 117.90 | -953.45 | 21.35 | 495.80 | 140.80 | 94.55 |
EBITDA | 210.68B | -258.31B | 110.63B | 338.23B | 272.22B | 282.44B |
EBIT | 210.68B | -415.83B | -57.33B | 181.57B | 136.2B | 150.7B |
Depreciation & Amortization | 131.6B | 157.52B | 167.96B | 156.67B | 136.02B | 131.74B |
Add to Watchlist
Select watchlists to add or remove SOMMY